Evidence map›Paper›PMID 35387497›Full record

ArticleJournal of clinical microbiology2022

Development of a Bead-Based Multiplex Assay for Use in Multianalyte Screening and Surveillance of HIV, Viral Hepatitis, Syphilis, and Herpes.

Ernest L Yufenyuy, Shanmugam Vedapuri, Amy Zheng, Gretchen Cooley, Damien Danavall, Shukla Mayur, Maja Kodani, Cheng Chen, Ye Tun, Yetunde F Fakile and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Ernest L YufenyuyDivision of Global HIV and TB, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.ORCID 0000-0002-0613-1373
Shanmugam VedapuriDivision of Global HIV and TB, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Amy ZhengDivision of Global HIV and TB, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Gretchen CooleyDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Damien DanavallDivision of STD Prevention, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Shukla MayurDivision of STD Prevention, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Maja KodaniDivision of Viral Hepatitis, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Cheng ChenDivision of STD Prevention, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Ye TunCenter for Global Health, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Yetunde F FakileDivision of STD Prevention, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Diana MartinDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.ORCID 0000-0001-9417-5562
Saleem KamiliDivision of Viral Hepatitis, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Kevin KaremCenter for Global Health, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Bharat S ParekhDivision of Global HIV and TB, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · US

Funding

Centers for Disease Control and Prevention Innovative Funding
6 · The paper itself

Abstract

Diagnostic assays that can simultaneously determine the presence of infection with multiple pathogens are key for diagnosis and surveillance. Current multiplex diagnostic assays are complex and often have limited availability. We developed a simple, multianalyte, pathogen detection assay for screening and serosurveillance using the Luminex Magpix platform that is high throughput and can be helpful in monitoring multiple diseases. The Luminex bead-based 10-plex immunoassay for the detection of HIV-1, HIV-2, Treponema pallidum, hepatitis B virus (HBV), hepatitis C virus (HCV), herpes simplex virus 1 (HSV-1), and HSV-2 infections was accomplished by coupling beads with specific antigens to detect IgG antibodies in plasma or serum samples. Each coupled antigen was systematically optimized, and the performance was evaluated using a panel of well-characterized specimens (

Indexed as

Hepatitis CHerpes SimplexHIV-1HIV InfectionsSyphilisHepacivirusHepatitis B virusHIV-2HumansSensitivity and SpecificityTreponema pallidumblood-bornemultipathogenmultiplex

Identifiers

PMID35387497
PMCPMC9116187
OpenAlexW4226020091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.